The brain tumor window model: A combined cranial window and implanted glioma model for evaluating iIntraoperative contrast agents

Neurosurgery

Volumn 66, Issue 4, 2010, Pages 736-743

  Orringer, Daniel A ^a   Chen, Thomas ^b   Huang, Dah Luen ^a   Armstead, William M ^c   Hoff, Benjamin A ^b   Koo, Yong Eun L ^b   Keep, Richard F ^a   Philbert, Martin A ^b   Kopelman, Raoul ^b   Sagher, Oren ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain tumor; Cranial window; Intraoperative imaging

Indexed keywords

ANAZOLENE SODIUM; CONTRAST MEDIUM; GADOLINIUM PENTETATE MEGLUMINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CANCER GRAFT; COMPUTER ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CRANIECTOMY; GLIOMA; GLIOMA CELL; IMAGE ANALYSIS; INTRAOPERATIVE PERIOD; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR MODEL;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; GLIOMA; MAGNETIC RESONANCE IMAGING; NEOPLASM TRANSPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 77949998326     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000367631.02903.50     Document Type: Article

References (24)

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States statistical report. Central Brain Tumor Registry of the United States. http://www.cbtrus.org/reports//2007-2008/ 2007report.pdf. Accessed January 22, 2010.
2. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62(4):753-766.
3. Britz G, Ghatan S, Spence AM, Berger MS. Intracarotid RMP-7 enhanced indocyanine green staining of tumors in a rat glioma model. J Neurooncol. 2002;56(3):227-232.
4. Hansen DA, Spence AM, Carski T, Berger MS. Indocyanine green (ICG) staining and demarcation of tumor margins in a rat glioma model. Surg Neurol. 1993;40(6):451-456.
5. Moore GE. Fluorescein as an agent in the differentiation of normal and malignant tissues. Science. 1947;106(2745):130-131.
6. Moore GE, Peyton WT. The clinical use of fluorescein in neurosurgery; the localization of brain tumors. J Neurosurg. 1948;5(4):392-398.
7. Ozawa T, Britz GW, KinDerDH, Spence AM, VandenBerg S, Lamborn KR, Deen DF, Berger MS. Bromophenol blue staining of tumors in a rat glioma model. Neurosurgery. 2005;57(5):1041-1047.
8. Shinoda J, Yano H, Yoshimura S, et al. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium: technical note. J Neurosurg. 2003;99(3):597-603.
9. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392-401.
10. Veiseh M, Gabikian P, Bahrami SB, et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res. 2007;67(14):6882-6888.
11. Reddy GR, Bhojani MS, McConville P, et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res. 2006;12(22):6677-6686.
12. Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M. Low-graDegliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg. 1995;82(4):536-547.
13. Rutka JT, Kuo JS. Pediatric surgical neuro-oncology: current best care practices and strategies. J Neurooncol. 2004;69(1-3):139-150.
14. Kremer P, Mahmoudreza F, Ding R, Pritsch M, Zoubaa S, Frei E. Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin. Neurosurgery. 2009;64(suppl 3):53-61.
15. Orringer DA, Koo YE, Chen T, Kopelman R, Sagher O, Philbert MA. Small solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapy. Clin Pharmacol Ther. 2009;85(5):531-534.
16. Barker M, Hoshino T, Gurcay O, et al. Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1- nitrosourea. Cancer Res. 33(5):976-986.
17. Barth RF. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol. 1998;36(1):91-102.
18. Black KL, Yin D, Konda BM, et al. Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models. Brain Res. 2008;Aug 28;1227:198-206.
19. Brian JE Jr, Faraci FM. Tumor necrosis factor-α-induced dilatation of cerebral arterioles. Stroke. 1998;29(2):509-515.
20. Fujita H, Matsuura T, Yamada K, Inagaki N, Kanno I. A sealed cranial window system for simultaneous recording of blood flow, and electrical and optical signals in the rat barrel cortex. J Neurosci Methods. 2000;99(1-2):71-78.
21. MorII S, Ngai AC, Winn HR. Reactivity of rat pial arterioles and venules to adenosine and carbon dioxide: with detailed description of the closed cranial window technique in rats. J Cereb Blood Flow Metab. 1986;6(1):34-41.
22. Meno JR, Nguyen TS, Jensen EM, et al. Effect of caffeine on cerebral blood flow response to somatosensory stimulation. J Cereb Blood Flow Metab. 2005;25(6):775-784.
23. Foltz RM, McLendon RE, Friedman HS, Dodge RK, Bigner DD, Dewhirst MW. A pial window model for the intracranial study of human glioma microvascular function. Neurosurgery. 1995;36(5):976-985.
24. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 1994;54(17):4564-4568.